True North Advisors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
16,071
+1,683
+12% +$114K 0.11% 110
2026
Q1
$1.08M Buy
14,388
+1,714
+14% +$140K 0.12% 104
2025
Q4
$990K Buy
12,674
+1,731
+16% +$140K 0.13% 114
2025
Q3
$930K Sell
10,943
-672
-6% -$53.8K 0.15% 90
2025
Q2
$908K Buy
11,615
+1,714
+17% +$126K 0.17% 101
2025
Q1
$716K Buy
9,901
+1,145
+13% +$96.1K 0.13% 111
2024
Q4
$777K Buy
8,756
+930
+12% +$82.9K 0.18% 74
2024
Q3
$662K Buy
7,826
+1,438
+23% +$128K 0.17% 84
2024
Q2
$590K Buy
6,388
+1,237
+24% +$125K 0.16% 97
2024
Q1
$581K Sell
5,151
-868
-14% -$86.7K 0.16% 101
2023
Q4
$561K Buy
6,019
+265
+5% +$23.3K 0.14% 96
2023
Q3
$528K Buy
5,754
+932
+19% +$100K 0.16% 108
2023
Q2
$585K Buy
4,822
+932
+24% +$100K 0.17% 114
2023
Q1
$381K Buy
3,890
+227
+6% +$21.7K 0.11% 141
2022
Q4
$297K Buy
3,663
+148
+4% +$12.4K 0.1% 138
2022
Q3
$267K Buy
3,515
+1,595
+83% +$153K 0.09% 151
2022
Q2
$209K Buy
+1,920
New +$204K 0.07% 178

Other funds holding USPH

True North Advisors's USPH Position: Q2 2026 in Review

True North Advisors increased its US Physical Therapy (USPH) stake by 12% in Q2 2026, buying an estimated $114K and bringing the position to 16,071 shares worth $1.1M. The position accounts for 0.11% of the portfolio, ranked #110.

True North Advisors first reported a position in USPH in Q2 2022 and has held it in 17 quarters since. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • True North Advisors held 16,071 shares of US Physical Therapy worth $1.1M as of Q2 2026.
  • True North Advisors bought 1,683 US Physical Therapy shares in Q2 2026, an estimated $114K.
  • US Physical Therapy made up 0.11% of True North Advisors's portfolio in Q2 2026, its #110 holding.
  • True North Advisors first reported a position in US Physical Therapy in Q2 2022 and has held it in 17 quarters since.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.